Phase II study of homoharringtonine in patients with recurrent primary malignant central nervous system tumors
- 1 October 1990
- journal article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 9 (2) , 159-163
- https://doi.org/10.1007/bf02427837
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Central nervous system (CNS) penetration of homoharringtonine (HHT)Journal of Neuro-Oncology, 1987
- Intracarotid infusion of cis-diamminedichloroplatinum in the treatment of recurrent malignant brain tumorsCancer, 1984
- PHASE-I CLINICAL INVESTIGATION OF HOMOHARRINGTONINE1984
- A Critical Appraisal of the Human Tumor Stem-Cell AssayNew England Journal of Medicine, 1983
- Chemosensitivity of malignant human brain tumorsJournal of Neuro-Oncology, 1983
- Phase II study of cisplatin in recurrent astrocytomas in adults: A southwest oncology group studyJournal of Neuro-Oncology, 1983
- Heterogeneous chemosensitivities of subpopulations of human glioma cells in culture.1982
- Antitumor Alkaloids from Cephalotaxus harringtonia: Structure and ActivityJournal of Pharmaceutical Sciences, 1972